£1.2M
HERmesa led the pre-seed round, which includes backing from multiple institutional investors and Innovate UK grants.
"When only a small minority can deliver best practice, the problem isn’t effort. It’s design. I brought what I was seeing in practice, and I brought the evidence that already existed but simply wasn’t being used consistently. Peripear exists because the standard of care couldn’t possibly be the best we could do,"
